Literature DB >> 19215836

Cardiac resynchronization therapy: are modern myths preventing appropriate use?

John G F Cleland1, Luigi Tavazzi2, Jean-Claude Daubert3, Ahmed Tageldien4, Nick Freemantle5.   

Abstract

Mesh：

Year:  2009        PMID： 19215836     DOI： 10.1016/j.jacc.2008.10.040

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

2.  Device therapy: Defibrillators-a shocking therapy for cardiomyopathy?

Authors:  John G F Cleland; Laszlo Buga
Journal:  Nat Rev Cardiol       Date:  2010-02       Impact factor: 32.419

Review 3.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 4.  The determinants of clinical outcome and clinical response to CRT are not the same.

Authors:  John G F Cleland; Stefano Ghio
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 5.  Profiling cardiac resynchronization therapy patients: responders, non-responders and those who cannot respond--the good, the bad and the ugly?

Authors:  Valerio Zacà; Sergio Mondillo; Rosaria Gaddi; Roberto Favilli
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-17       Impact factor: 2.357

Review 6.  Ventricular resynchronization is the principle mechanism of benefit with cardiac resynchronization therapy.

Authors:  John Gorcsan; Cheuk-Man Yu; John E Sanderson
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

7.  Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.

Authors:  Alison P Coletta; Andrew L Clark; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

8.  Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.

Authors:  Stefano Coiro; Nicolas Girerd; John J V McMurray; Bertram Pitt; Karl Swedberg; Dirk J van Veldhuisen; Zohra Lamiral; Patrick Rossignol; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2021-05-06       Impact factor: 5.460

9.  Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.

Authors:  Rutger J van Bommel; Hidekazu Tanaka; Victoria Delgado; Matteo Bertini; Carel Jan Willem Borleffs; Nina Ajmone Marsan; Johannes Holzmeister; Frank Ruschitzka; Martin J Schalij; Jeroen J Bax; John Gorcsan
Journal:  Eur Heart J       Date:  2010-09-23       Impact factor: 29.983

10.  Development and course of heart failure after a myocardial infarction in younger and older people.

Authors:  Azam Torabi; John Gf Cleland; Alan S Rigby; Nasser Sherwi
Journal:  J Geriatr Cardiol       Date:  2014-03       Impact factor: 3.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.